TOTAL: $454.3M
 
Company Location Date Amt. (M) Details

Anaphore Inc. La Jolla, Calif. 5/13 $13 Anaphore raised $13M to top off its original $25M Series A financing it closed on in January; SR One and Merck Serono Ventures invested in the extension, as did Aravis Venture
 
Applied Genetic Technologies Corp. Gainesville, Fla. 5/1 $11.8 Applied Genetic raised $11.8M in a round led by InterWest Partners; other participants were Intersouth Partners and MedImmune Ventures Inc.
 
Aragon Pharmaceuticals La Jolla, Calif. 5/20 $8 Aragon raised $8M in a Series A financing led by the Column Group and OrbiMed Advisors
 
Avid Radio-pharmaceuticals Inc. Philadelphia 5/21 $34.5 Avid raised $34.5M in a Series D led by Alta Partners; other investors were AllianceBernstein, Safeguard Scientifics, Pfizer Venture Investments, Lilly Ventures, RK Ventures Group LLC and BioAdvance
 
Calistoga Pharmaceuticals Inc. Seattle 5/5 $30 Calistoga raised $30M in a Series B round from Alta Partners, Amgen Ventures, Frazier Healthcare and Three Arch Partners
 
Cempra Pharmaceuticals Inc. Research Triangle Park, N.C. 5/14 $46 Cempra raised $46M in a Series C financing round led by Quaker BioVentures; other investors were Devon Park Bioventures, Aisling Capital, Intersouth Partners, Wistar Morris III and Teacher's Private Capital
 
Clovis Oncology Inc. Boulder, Colo. 5/21 $145 Clovis raised $145M in start-up funds from Domain Associates, New Enterprise Associates, Versant Ventures, Aberdare Ventures, Abingworth, Frazier Healthcare Ventures and ProQuest Investments
 
Elixir Pharmaceuticals Inc. Cambridge, Mass. 5/19 $12 Elixir raised $12M in a financing led by MPM Capital and Physic Ventures, and included ARCH Venture Partners, Oxford Bioscience Partners and the Omega Fund
 
NanoTherapies LLC (subsidiary of Keystone Nano Inc.) Boalsburg, Pa. 5/12 ND Cancer Therapeutics Inc. signed a letter of intent to acquire a minority ownership share of NanoTherapies in an equity transaction
 
NovImmune SA Plan-Les-Ouates, Switzerland 5/11 CHF62.5
($56.5)
NovImmune raised $56.5M in a financing led by BZ Bank AG
 
PlexPress Los Altos, Calif. 5/12 $2.75 PlexPress closed a $2.75M seed round from Conor Technology Fund I, Veraventure, Helsinki University Fund and VTT
 
Proteon Therapeutics Inc. Waltham, Mass. 5/28 $12 Proteon completed a second closing of its Series B equity financing, bringing the total raised to $50M; investors were Bessemer Venture Partners and Devon Park Bioventures
 
Sagent Pharmaceuticals Inc. Schaumburg, Ill. 5/21 $30 Sagent raised $30M in a second Series A financing led by Vivo Ventures
 
Sirona Biochem Corp. Vancouver, British Columbia 5/4 $0.75 Sirona raised $751,975 from TFChem SARI in exchange for 5M units at 15 cents each
 
Tokai Pharmaceuticals Cambridge, Mass. 5/8 $22 Tokai closed a $22M Series D round led by Novartis Venture Fund; Apple Tree Partners also invested in the round
 
VaxInnate Corp. Cranbury, N.J. 5/6 $30 VaxInnate raised $30M in a Series D financing led by new investor the Wellcome Trust; other investors were New Leaf Venture Partners, Canaan Partners, HealthCare Ventures, Oxford Bioscience Partners, MedImmune Ventures and CHL Medical Ventures

Notes:
Currency conversions are based on exchange rates at the time of the deal.
** Denotes the date the item ran in BioWorld International.
ND = Not disclosed.